(Q43207643)

16 November 2017

title

Visfatin is a positive regulator of MCP-1 in human adipocytes in vitro and in mice in vivo (English)

1 reference

16 November 2017

1 reference

11

Mathias Fasshauer

1 reference

16 November 2017

10

Michael Stumvoll

1 reference

16 November 2017

2

Susan Kralisch

1 reference

16 November 2017

8

Ulrike Lossner

1 reference

16 November 2017

9

Matthias Bluher

1 reference

16 November 2017

3

Nora Kloting

1 reference

16 November 2017

7

Anke Tonjes

1 reference

16 November 2017

1

Grit Sommer

1 reference

16 November 2017

4

Manja Kamprad

1 reference

16 November 2017

Kathleen Schrock

5

1 reference

16 November 2017

Jurgen Kratzsch

series ordinal

6

1 reference

16 November 2017

publication date

24 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

volume

18

1 reference

16 November 2017

issue

8

1 reference

16 November 2017

page(s)

1486-1492

1 reference

Inflammation and the etiology of type 2 diabetes

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Chemokines in the pathogenesis of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Monocyte chemoattractant protein 1 in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Monocyte chemoattractant protein-1 in human atheromatous plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

The perils of portliness: causes and consequences of visceral adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Molecular Characteristics of Serum Visfatin and Differential Detection by Immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Circulating visfatin level is correlated with inflammation, but not with insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Serum levels of adipokine retinol-binding protein-4 in relation to renal function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.462

31 March 2020

Identifiers

DOI

10.1038/OBY.2009.462

1 reference

16 November 2017

1 reference